1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-163888
    NO-IN-1 Inhibitor
    NO-IN-1 (Compound 7a) 抑制 NO 的产生 (IC50 = 3.13 μΜ)。NO-IN-1 具有抗炎作用。NO-IN-1 通过抑制 NF-κB 信号通路下调 COX-2iNOS 的表达。
    NO-IN-1
  • HY-B0808S1
    Oxaprozin-d5

    奥沙普秦-d5

    Inhibitor
    Oxaprozin-d5 是 Oxaprozin 氘代物。Oxaprozin 是 COX-1COX-2 的抑制剂,对人类血小板 COX-1IL-1 刺激的人类滑膜细胞 COX-2IC50 值分别为 2.2 和 36 μM。Oxaprozin 还能抑制 NF-κB 的活化。
    Oxaprozin-d<sub>5</sub>
  • HY-N8903
    Mumefural Inhibitor
    Mumefural 是 Prunus mume Sieb 加工果实中的一种生物活性成分。Mumefural 抑制血小板聚集。Mumefural 显示抗血栓作用,改善认知障碍。
    Mumefural
  • HY-126741R
    Azadirachtin (Standard)

    印楝素 (Standard)

    Inhibitor
    Azadirachtin (Standard) 是 Azadirachtin 的分析标准品。本产品用于研究及分析应用。Azadirachtin,有前途的植物源杀虫剂之一,广泛用于害虫防治。Azadirachtin 诱导昆虫 Sf9、SL-1 和 BTI-Tn-5B1-4 细胞凋亡。
    Azadirachtin (Standard)
  • HY-N0589R
    Dehydrodiisoeugenol (Standard)

    脱氢二异丁香酚 (Standard)

    Inhibitor
    Dehydrodiisoeugenol (Standard) 是 Dehydrodiisoeugenol 的分析标准品。本产品用于研究及分析应用。Dehydrodiisoeugenol 从 Myristica fragrans Houtt 中分离得到,具有抗炎和抗菌作用。Dehydrodiisoeugenol 抑制 LPS 刺激的小鼠巨噬细胞中 NF-κB 活化和环氧合酶 (COX)-2 基因的表达。
    Dehydrodiisoeugenol (Standard)
  • HY-157211
    Anti-inflammatory agent 66 Inhibitor
    Anti-inflammatory agent 66 (compound 8) 是具有抗炎活性的紫檀芪衍生物。Anti-inflammatory agent 66 通过阻断 LPS 诱导的 NF-κB/MAPK 信号通路来抑制促炎细胞因子,并有效缓解 DSS 诱导的小鼠急性结肠炎。
    Anti-inflammatory agent 66
  • HY-159719
    NLRP3-IN-51 Inhibitor
    NLRP3-IN-51 (Compound 3q) 是一种有效的胆碱能抗炎通路 (CAP) 激活剂。NLRP3-IN-51 抑制 THP-1 细胞中尿酸钠 (MSU) (HY-B2130A) 诱导的 IL-1β 产生,表明其具有抗痛风性关节炎的潜力。NLRP3-IN-51 抑制 MSU 诱导的 NF-κB p65 磷酸化,而对 NLRP3、pro-caspase 1 或第二信号传导的 caspase-1 的自我裂解和激活没有任何抑制作用。因此,NLRP3-IN-51 通过 CAP 激活抑制 NLRP3 的初始阶段。
    NLRP3-IN-51
  • HY-N0256R
    Hederagenin (Standard)

    常春藤皂苷元 (Standard)

    Inhibitor
    Hederagenin (Standard)是 Hederagenin 的分析标准品。本产品用于研究及分析应用。Hederagenin 是三萜皂苷,具有口服活性和抗肿瘤活性。Hederagenin 能够抑制细胞中由于 LPS 刺激引起的 iNOSCOX-2,和 NF-κB 的表达。Hederagenin 还增加癌细胞中 ROS 产生,破坏线粒体膜电位,诱导细胞凋亡 (apoptosis)。Hederagenin 还增加癌细胞对 Cisplatin (HY-17394) 和 Paclitaxel (HY-
    Hederagenin (Standard)
  • HY-N0622R
    Morusin (Standard)

    桑辛素 (Standard)

    Inhibitor
    Morusin (Standard) 是 Morusin 的分析标准品。本产品用于研究及分析应用。Morusin是从Morus alba Linn.分离的去乙烯基化黄酮,具有抗肿瘤,抗氧化,抗菌等各种生物活性。Morusin可抑制 NF-κBSTAT3 的活性。
    Morusin (Standard)
  • HY-134000
    Emodic acid Inhibitor
    Emodic acid(NSC624610) 是一种从 A. microcarpus 中分离出来的蒽醌类化合物,可以通过 NF-κB 的活性抑制,从而抑制癌细胞增殖。Emodic acid 也可以抑制 p38ERKJNK 的磷酸化,促肿瘤细胞因子 IL-1β 和 IL-6 的分泌,以及 VEGFMMP 的表达,进而抑制癌细胞的侵袭和迁移潜能。
    Emodic acid
  • HY-168070
    COX-2-IN-48 Inhibitor
    COX-2-IN-48 (5-25) 是 COX-2 的抑制剂,其对人 COX-2IC50 为51.7 nM,通过抑制NF-κB通路在多种啮齿动物模型中发挥抗炎和镇痛作用。COX-2-IN-48 (5-25) 抑制 IκB 的降解、NF-κB p65 的磷酸化和核转位,以及 COX-2 和iNOS 的表达。
    COX-2-IN-48
  • HY-146058
    NF-κB/PON1-IN-1 Inhibitor
    NF-κB/PON1-IN-1 (Compound 16) 是一种 NF-κB/PON1 通路抑制剂。NF-κB/PON1-IN-1 具有抗氧化活性 (antioxidant) (IC50 = 45.76 µM) 和 保护肝脏活性。
    NF-κB/PON1-IN-1
  • HY-149087
    MR2938 Inhibitor
    MR2938 是一种有效的 AChE 抑制剂,IC50 为 5.04 μM。 MR2938 也明显抑制 NO 的产生 (IC50 = 3.29 μM)。 MR2938 通过阻断 MAPK/JNKNF-κB 信号通路抑制神经炎症。 MR2938 可用于阿尔茨海默病 (AD) 研究。
    MR2938
  • HY-D0162R
    Malachite green hemioxalate (Standard)

    孔雀石绿草酸盐 (Standard)

    Inhibitor
    Malachite green (hemioxalate) (Standard)是 Malachite green (hemioxalate) 的分析标准品。本产品用于研究及分析应用。Malachite green hemioxalate 是一种三苯基甲烷染料,可用于检测酶促反应中磷酸盐的释放。Malachite green hemioxalate 也是一种有效和选择性的 IKBKE 抑制剂,同时抑制其下游靶标,如 IκBαp65IRF3。Malachite green hemioxalate 在体外和体内均表现出抗肿瘤活性。
    Malachite green hemioxalate (Standard)
  • HY-N0043R
    Ginsenoside Rd (Standard)

    人参皂苷 Rd (Standard)

    Inhibitor
    Ginsenoside Rd (Standard)是 Ginsenoside Rd 的分析标准品。本产品用于研究及分析应用。Ginsenoside Rd 抑制 TNFα 诱导的 NF-κB 转录活性,IC50 为 12.05±0.82 μM。Ginsenoside Rd 抑制 COX-2iNOS mRNA 的表达。Ginsenoside Rd 还抑制 Ca2+ 内流。Ginsenosid
    Ginsenoside Rd (Standard)
  • HY-149580
    NF-κB-IN-12 Inhibitor
    NF-κB-IN-12 (compound 3h) 是一种有效的 NF-κB 抑制剂,IC50 为 1.02 μM。NF-κB-IN-12 可用于急性肺损伤研究。
    NF-κB-IN-12
  • HY-147836
    Akt/NF-κB/JNK-IN-1 Inhibitor
    Akt/NF-κB/JNK-IN-1 (Compound 2i) 是一种 Akt, NF-κBJNK 信号通路抑制剂。Akt/NF-κB/JNK-IN-1 抑制一氧化氮的产生,IC50 为 3.15 μM。Akt/NF-κB/JNK-IN-1 具有抗炎活性。
    Akt/NF-κB/JNK-IN-1
  • HY-N0755R
    Rhoifolin (Standard)

    野漆树苷 (Standard)

    Activator
    Rhoifolin (Standard) 是 Rhoifolin 的分析标准品。本产品用于研究及分析应用。Rhoifolin 是一种黄酮糖苷,可从野洋漆分离。 Rhoifolin 通过增强脂联素分泌、胰岛素受体-β (insulin receptor-β) 的酪氨酸磷酸化和 GLUT4 易位来发挥抗糖尿病作用。Rhoifolin 通过对炎症介质的多层次调控发挥抗炎作用。Rhoifolin 通过 RANKL 诱导的 NF-κBMAPK 途径改善钛颗粒刺激的骨溶解并减弱破骨细胞生成。Rhoifolin 对多种癌细胞系也具有细胞毒性活性。
    Rhoifolin (Standard)
  • HY-147770
    NF-κB-IN-6 Inhibitor
    NF-κB-IN-6 (Compound 3d) 是一种抗炎剂,通过抑制 NF-κB 信号通路减少 iNOSCOX-2 蛋白的表达。NF-κB-IN-6 抑制 RAW264.7 细胞中 LPS 诱导的 NO 的产生,IC50 值为 23.1 μM。
    NF-κB-IN-6
  • HY-N0822R
    Shikonin (Standard)

    紫草素 (Standard)

    Inhibitor
    Shikonin (Standard) 是 Shikonin 的分析标准品。本产品用于研究及分析应用。Shikonin 是中草药紫草的主要成分。Shikonin 是一种有效的 TMEM16A 氯化物通道 (chloride channel) 抑制剂,IC50 为 6.5 μM。Shikonin 是一种特异的丙酮酸激酶 M2 (PKM2) 抑制剂,还可以抑制 TNF-αNF-κB途径。Shikonin 通过抑制糖酵解降低外泌体 (exosome) 的分泌。Shikonin 抑制 AIM2炎性体活化。
    Shikonin (Standard)
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.